Status:
COMPLETED
The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach
Lead Sponsor:
Nanjing University School of Medicine
Conditions:
Prostatectomy
Prostate Neoplasm
Eligibility:
MALE
Brief Summary
The goal of this observational study was to compare the perioperative outcomes, postoperative urinary control rates and positive surgical margin (PSM) rates of the robot-assisted laparoscopic radical ...
Eligibility Criteria
Inclusion
- pathologically diagnosed with prostate cancer by prostate biopsy
- underwent robot-assisted laparoscopic surgery
- the surgery performed by Weidong Gan
- the extended pelvic lymphadenectomy (PLA) is performed on patients with high-risk prostate cancer (PSA≥20 ng/ml or Grade Group 4-5 or clinical stage ≥T2c) and those considered to have a possibility of lymph node metastasis based on imaging evaluation.
Exclusion
- Patients with a clinical and pathological TNM stage ≥T3b and N1
- patients with distant metastasis
- urinary incontinence before surgery
- received neoadjuvant therapy before surgery
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 27 2022
Estimated Enrollment :
233 Patients enrolled
Trial Details
Trial ID
NCT06020287
Start Date
September 1 2020
End Date
December 27 2022
Last Update
August 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China, 210008